Wells Fargo & Company Evolent Health, Inc. Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Evolent Health, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 69,450 shares of EVH stock, worth $692,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,450
Previous 90,206 23.01%
Holding current value
$692,416
Previous $2.55 Million 69.38%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$10.71 - $27.14 $222,296 - $563,317
-20,756 Reduced 23.01%
69,450 $781,000
Q3 2024

Nov 13, 2024
SELL
$18.41 - $32.97 $15,372 - $27,529
-835 Reduced 0.92%
90,206 $2.55 Million
Q2 2024

Aug 13, 2024
BUY
$19.12 - $31.93 $33,192 - $55,430
1,736 Added 1.94%
91,041 $1.74 Million
Q1 2024

May 10, 2024
BUY
$29.41 - $34.72 $164,460 - $194,154
5,592 Added 6.68%
89,305 $2.93 Million
Q4 2023

Feb 09, 2024
BUY
$23.63 - $33.52 $83,437 - $118,359
3,531 Added 4.4%
83,713 $2.77 Million
Q3 2023

Nov 13, 2023
SELL
$25.0 - $31.4 $1.13 Million - $1.42 Million
-45,240 Reduced 36.07%
80,182 $2.18 Million
Q2 2023

Aug 15, 2023
BUY
$28.05 - $36.44 $217,443 - $282,482
7,752 Added 6.59%
125,422 $3.8 Million
Q1 2023

May 12, 2023
BUY
$26.35 - $35.8 $919,035 - $1.25 Million
34,878 Added 42.13%
117,670 $3.82 Million
Q4 2022

Feb 13, 2023
SELL
$22.21 - $37.41 $100,366 - $169,055
-4,519 Reduced 5.18%
82,792 $2.32 Million
Q3 2022

Nov 14, 2022
SELL
$29.37 - $39.74 $132,693 - $179,545
-4,518 Reduced 4.92%
87,311 $3.14 Million
Q2 2022

Aug 12, 2022
SELL
$25.9 - $32.26 $2.89 Million - $3.6 Million
-111,452 Reduced 54.83%
91,829 $2.82 Million
Q1 2022

May 16, 2022
SELL
$22.14 - $32.3 $1.33 Million - $1.94 Million
-60,091 Reduced 22.82%
203,281 $6.57 Million
Q4 2021

Feb 14, 2022
SELL
$25.36 - $34.11 $964,592 - $1.3 Million
-38,036 Reduced 12.62%
263,372 $7.29 Million
Q3 2021

Nov 15, 2021
BUY
$20.93 - $31.0 $451,188 - $668,267
21,557 Added 7.7%
301,408 $9.34 Million
Q2 2021

Aug 16, 2021
SELL
$18.43 - $21.78 $640,202 - $756,571
-34,737 Reduced 11.04%
279,851 $5.91 Million
Q1 2021

May 13, 2021
SELL
$16.19 - $21.22 $1.22 Million - $1.6 Million
-75,582 Reduced 19.37%
314,588 $6.36 Million
Q4 2020

Feb 09, 2021
SELL
$9.92 - $16.43 $755,765 - $1.25 Million
-76,186 Reduced 16.34%
390,170 $6.26 Million
Q3 2020

Nov 05, 2020
BUY
$7.4 - $14.33 $259,488 - $502,495
35,066 Added 8.13%
466,356 $5.79 Million
Q2 2020

Aug 13, 2020
BUY
$4.8 - $9.42 $540,316 - $1.06 Million
112,566 Added 35.32%
431,290 $3.07 Million
Q1 2020

May 14, 2020
BUY
$3.64 - $11.77 $1.16 Million - $3.75 Million
318,724 New
318,724 $1.73 Million

Others Institutions Holding EVH

# of Institutions
298
Shares Held
122M
Call Options Held
2.12M
Put Options Held
2.53M
View Full List

About Evolent Health, Inc.

EVH Quotes by TradingView
  • Ticker EVH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 97,063,696
  • Market Cap $968M
  • Description
  • Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...
More about EVH
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email